Cargando…
Effects of odanacatib on bone matrix mineralization in rhesus monkeys are similar to those of alendronate
Odanacatib (ODN) is a selective and reversible inhibitor of cathepsin K which is an important enzyme for the degradation of collagen I. Aim of the present work was the head-to-head comparison between the effects of ODN and alendronate (ALN) on bone mineralization density distribution (BMDD), based o...
Autores principales: | Misof, Barbara M., Roschger, Paul, Chen, Charles, Pickarski, Maureen, Messmer, Phaedra, Klaushofer, Klaus, Duong, Le T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926807/ https://www.ncbi.nlm.nih.gov/pubmed/28326348 http://dx.doi.org/10.1016/j.bonr.2016.03.001 |
Ejemplares similares
-
Bone matrix mineralization and osteocyte lacunae characteristics in patients with chronic kidney disease - mineral bone disorder (CKD-MBD)
por: Misof, Barbara M., et al.
Publicado: (2019) -
The Bone Resorption Inhibitors Odanacatib and Alendronate Affect Post-Osteoclastic Events Differently in Ovariectomized Rabbits
por: Jensen, Pia Rosgaard, et al.
Publicado: (2013) -
No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patients
por: Misof, Barbara M., et al.
Publicado: (2020) -
Odanacatib increases mineralized callus during fracture healing in a rabbit ulnar osteotomy model
por: Pennypacker, Brenda L., et al.
Publicado: (2015) -
Baseline mineralizing surface determines the magnitude of the bisphosphonate effect on cortical bone mineralization in postmenopausal osteoporotic patients
por: Misof, B.M., et al.
Publicado: (2017)